rejuvant life tabs

Start-up Sentai wins UK independent living grant

Latest articles

Paving the way to future organ factories

Extracellular matrix obtained by controlled decellularisation is used to reconstruct the liver with human-like characteristics, paving the way for transplantable livers. Researchers at the Human...

Charles Brenner: the journey from NR to Tru Niagen

Dr Charles Brenner, the developer of the intellectual property behind ChromaDex's Tru Niagen, on all things metabolism, NAD and NR clinical trials. Longevity.Technology: Following the...

Longevity investment firm announces acceleration programme

Call for future founders: longevity investment fund LongeVC announces in-house acceleration programme. LongeVC – a longevity investment group backed by an advisory board with solid...

The placenta: a limitless source of stem cells?

Part 1 of our exclusive interview with Celularity founder Dr Robert Hariri covers the discovery of placental pluripotent stem cells and the journey towards...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...
Supplement report

Editor's picks

Paving the way to future organ factories

Extracellular matrix obtained by controlled decellularisation is used to reconstruct the liver with human-like characteristics, paving the way for transplantable livers. Researchers at the Human...

Charles Brenner: the journey from NR to Tru Niagen

Dr Charles Brenner, the developer of the intellectual property behind ChromaDex's Tru Niagen, on all things metabolism, NAD and NR clinical trials. Longevity.Technology: Following the...

Longevity investment firm announces acceleration programme

Call for future founders: longevity investment fund LongeVC announces in-house acceleration programme. LongeVC – a longevity investment group backed by an advisory board with solid...
Rejuvant

Machine-learning smart device uses AI to promote independence and safety.

A British technology start-up focused on helping the elderly live more independently in their own home has received financial backing from the UK Government. Accelerated by the coronavirus crisis and rising loneliness amongst the elderly, Sentai, a portable smart device using AI and Augmented Voice Technology to monitor and support older people, has received a grant from Innovate UK, the UK’s innovation agency.

Longevity.Technology:  This device concept hits the market at a time when it is estimated 1.4 million people aged 50 and over in England alone suffer from loneliness. And with the number of people in Europe aged 80 and over expected to more than double by 2070, from 29 million to over 60 million, the need to support and monitor the elderly will be crucial in a post-pandemic world.

Thanks to advancements in machine-learning capabilities, Sentai can provide a contextual experience with the user, meaning conversations feel natural rather than robotic or one way. For example, it can detect the mood of a person from their voice and centre responses around that, whilst providing timely prompts around important things such as medication.

The idea is to offer a small, discreet, personal task force to deal with the day-to-day care needs of the elderly, whilst keeping them connected to their loved ones and community. The caregiver can stay connected via a smart app, with daily performance logs and push notifications enabling them to get peace of mind.

Phil Marshman, Sentai’s CEO and founder, said: “We’re delighted to see the Government backing us under the Sustainable Innovation Fund, as it serves to underline how much our product is needed. With winter fast approaching and another national lockdown underway, loneliness is only set to rise further, and we want to be able to ensure our loved ones are monitored and supported when we can’t physically be with them.”

 


 

“We’re now one step closer to making Sentai accessible to all who need it and incredibly excited at the prospect of being able to offer a viable solution to combatting loneliness, thereby improving quality of life and ensuring peace of mind.”

 


 

He continued: “We’re now one step closer to making Sentai accessible to all who need it and incredibly excited at the prospect of being able to offer a viable solution to combatting loneliness, thereby improving quality of life and ensuring peace of mind.”

Elevant

Also, equipped with sensors, Sentai monitors movements and can call for help if someone falls, and can remind them to take medication throughout the day as needed.

Dr Ian Campbell, Executive Chair of Innovate UK, said: “In these difficult times we have seen the best of British business innovation. The pandemic is not just a health emergency but one that impacts society and the economy.

“Sentai, along with every initiative Innovate UK has supported through this fund, is an important step forward in driving sustainable economic development. Each one is also helping to realise the ambitions of hard-working people.”

Innovate UK is investing up to £191million to fund research and development projects with the aim of helping all sectors of the UK rebuild after the effects of COVID-19, the fund is supporting 1,103 projects and 1,189 UK businesses, totalling over £130million in aid.

Elevant

We recently reported how the UK’s Industrial Strategy Challenge Fund has developed a programme to promote new healthy aging solutions. The Healthy Aging Investment Accelerator is a five-year initiative to support smaller tech companies who are working to combat health issues related to the aging process, and is part of the UK Government’s commitment to developing the role technology can play in improving healthcare.

To further help get the device into the homes of people who need it, Sentai is preparing to launch a Kickstarter campaign to raise funds for the next stage of its development – the success of which will see its pioneering technology brought to mass market. Details of the Kickstarter are due to be announced imminently.

Image courtesy of Sentai
Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.
Rejuvant

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...
Supplement report

Related articles

AXA and Microsoft launch one-stop digital health platform

Microsoft joins forces with AXA for ‘one-stop’ digital healthcare platform. One of Europe's leading insurance companies AXA has announced it has formed a partnership with...

Tectonic Therapeutic launches with $80m series A

To drug the 'undruggable' – Tectonic's series A financing to transform the discovery of novel G-protein coupled receptor (GPCR)-targeted therapies is co-led by Vida...

New investor offers funding to healthy aging innovators

A fifth investor has joined UK Research and Innovation (UKRI), providing matched funding for top small innovators to develop ideas for healthy aging. The new...

Connected care start-up targets aging-in-place

PCL Health monitors key vitals at home, providing caregivers with peace of mind and supporting aging-in-place. British start-up PCL Health (formerly Poonyah Care) is on...

AgeTech fund: focus on over-50s not millennials

Founding partner of 1843 Capital targets AgeTech investment opportunities with $13 million fund. Connecticut-based early stage investment firm 1843 Capital values diversity highly, and seeks...
Supps report ad middle